Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHERYL M BURGESS

Allopathic & Osteopathic Physicians Dermatology Procedural Dermatology

NPI
1881756872
CMS profile
130521
Location
WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$130,967.34

86 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $121,700.83 10
Travel and Lodging $7,096.88 32
Food and Beverage $2,136.06 43
Gift $33.57 1

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $107,384.53 63
MERZ NORTH AMERICA, INC. $22,981.19 12
Medimetriks Pharmaceuticals, Inc. $353.21 6
Regeneron Healthcare Solutions, Inc. $162.67 1
Incyte Corporation $67.49 3
REVANCE THERAPEUTICS, INC. $18.25 1

Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHERYL M BURGESS

NPI 1881756872 · CMS profile ID 130521

Allopathic & Osteopathic Physicians / Dermatology / Procedural Dermatology

WASHINGTON, DC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1881756872?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHERYL M BURGESS, NPI 1881756872, CMS profile ID 130521. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1881756872?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CHERYL M BURGESS, NPI 1881756872, CMS profile ID 130521. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1881756872?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CHERYL M BURGESS, NPI 1881756872, CMS profile ID 130521, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–86 of 86 matching records. This page contains 36 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1881756872?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

86 matching records · $130,967.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 86 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–86 of 86.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $53.6005/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179290 CMS
ABBVIE INC. $58.5005/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179292 CMS
ABBVIE INC. $128.2605/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179294 CMS
ABBVIE INC. $150.0005/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391927 CMS
ABBVIE INC. $146.2605/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179286 CMS
ABBVIE INC. $210.5605/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179288 CMS
Incyte Corporation $19.1304/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141198537 CMS
MERZ NORTH AMERICA, INC. $8,500.0004/17/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146368433 CMS
Incyte Corporation $19.5504/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141198539 CMS
ABBVIE INC. $27.1304/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391921 CMS
ABBVIE INC. $21.9804/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391923 CMS
ABBVIE INC. $7.9004/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391925 CMS
ABBVIE INC. $58.8904/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179280 CMS
ABBVIE INC. $32.9404/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179282 CMS
ABBVIE INC. $568.1904/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179284 CMS
ABBVIE INC. $228.1004/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179276 CMS
ABBVIE INC. $121.2004/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179278 CMS
MERZ NORTH AMERICA, INC. $36.4603/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146368449 CMS
ABBVIE INC. $38.6703/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391915 CMS
ABBVIE INC. $27.6703/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391917 CMS
ABBVIE INC. $9.3503/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391919 CMS
ABBVIE INC. $22.9303/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179268 CMS
ABBVIE INC. $38.4203/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179270 CMS
ABBVIE INC. $647.1903/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179272 CMS
ABBVIE INC. $36.7303/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179274 CMS
ABBVIE INC. $121.2003/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179264 CMS
ABBVIE INC. $228.1003/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179266 CMS
Medimetriks Pharmaceuticals, Inc. $24.6903/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089388935 CMS
Medimetriks Pharmaceuticals, Inc. $24.6903/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089388937 CMS
REVANCE THERAPEUTICS, INC. $18.2502/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147913677 CMS
ABBVIE INC. $4.3501/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391911 CMS
ABBVIE INC. $24.2001/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103391913 CMS
Medimetriks Pharmaceuticals, Inc. $153.1901/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089388943 CMS
ABBVIE INC. $34,390.0001/22/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103132491 CMS
ABBVIE INC. $126.3001/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104179262 CMS
Medimetriks Pharmaceuticals, Inc. $24.7501/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089388939 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,565.99 52
PY2020 $37,497.20 13
PY2021 $18,689.58 32
PY2022 $77,867.47 98
PY2023 $108,243.89 79
PY2024 $130,967.34 86
PY2025 $28,509.16 46

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $209,678.18 22
PY2024 Principal investigator $133,438.32 23
PY2023 Recipient $1,571.00 14
PY2023 Principal investigator $271,099.78 25
PY2022 Principal investigator $676,044.96 14
PY2021 Principal investigator $402,113.04 18
PY2020 Principal investigator $60,572.03 17
PY2019 Principal investigator $155,241.39 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,780.16 12/31/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY AND DERMATOLOGIC SURGERY MANAGEMENT LLC
Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVEDERM VOLITE XC Injectable Gel for Improvement in Neck Appearance No dispute reported 06/30/2026 1202533503
Principal investigator 1 ABBVIE INC. $10,702.42 12/31/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY AND DERMATOLOGIC SURGERY MANAGEMENT LLC
A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel-design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds No dispute reported 06/30/2026 1202534227
Principal investigator 1 ABBVIE INC. $140.00 12/18/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202531094
Principal investigator 1 ABBVIE INC. $12,627.50 12/04/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds No dispute reported 06/30/2026 1202526488
Principal investigator 1 ABBVIE INC. $40.00 11/13/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202524215
Principal investigator 1 ABBVIE INC. $24,012.15 11/05/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds No dispute reported 06/30/2026 1202522561
Principal investigator 1 ABBVIE INC. $2,783.20 10/16/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202517241
Principal investigator 1 ABBVIE INC. $45,393.00 10/09/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds No dispute reported 06/30/2026 1202516203
Principal investigator 1 ABBVIE INC. $7,288.50 09/19/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202511678
Principal investigator 1 ABBVIE INC. $19,125.45 09/04/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A prospective, multi-center, evaluator and subject-blinded, randomized, comparator-controlled, parallel design study to evaluate the safety and effectiveness of NOA LIFT compared to JUVeDERM VOLLURE XC for the correction of facial wrinkles and folds No dispute reported 06/30/2026 1202509752
Principal investigator 1 ABBVIE INC. $12,276.60 08/14/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202504771
Principal investigator 1 ABBVIE INC. $17,091.55 07/17/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202498530
Principal investigator 1 ABBVIE INC. $7,130.30 06/17/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202491873
Principal investigator 1 ABBVIE INC. $21,564.35 06/13/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202491429
Principal investigator 1 Janssen Research & Development, LLC $3,745.00 06/13/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg Wa Dc
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186283
Principal investigator 1 Janssen Research & Development, LLC $756.00 05/23/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg Wa Dc
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186329
Principal investigator 1 Janssen Research & Development, LLC $405.00 04/10/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg Wa Dc
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186196
Principal investigator 1 Janssen Research & Development, LLC $3,874.00 03/21/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg PC
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186189
Principal investigator 1 ABBVIE INC. $15,500.00 03/13/2025 Non-covered Recipient Entity
CENTER FOR DERMATOLOGY
M24-704 - A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVEDERM Products, KYBELLA, CoolSculpting Elite and SkinMedica Products (US Harmony) No dispute reported 06/30/2026 1202463263
Principal investigator 1 Janssen Research & Development, LLC $1,505.00 03/03/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg PC
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186212
Principal investigator 1 Janssen Research & Development, LLC $1,303.00 02/20/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg PC
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186291
Principal investigator 1 Janssen Research & Development, LLC $635.00 02/20/2025 Non-covered Recipient Entity
Ctr For Derm and Dermatologic Surg PC
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE) No dispute reported 06/30/2026 1175186344